Viewing Study NCT03670667


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-27 @ 1:09 AM
Study NCT ID: NCT03670667
Status: COMPLETED
Last Update Posted: 2022-05-18
First Post: 2018-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IM101-674
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators